Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhdbitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo

This publication has 16 references indexed in Scilit:

• Shear-induced platelet aggregation in cerebral ischemia.
  Stroke, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase
  Cellular Signalling, 1992
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
  Journal of Clinical Investigation, 1991
• Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
  Circulation Research, 1990
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin
  Blood, 1988
• Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography
  Biochemical Pharmacology, 1984
• Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.
  Journal of Clinical Investigation, 1982
• Adenosine diphosphate induces binding of von Willebrand factor to human platelets
  Nature, 1982